Trial intelligence / Profile preview

Combination of SHR8554 and Riminkefon for Pain After Abdominal Surgery

NCT05470049Phase 2Unknown

Sponsor
Hengrui
Start
Aug 2022
Primary completion
Nov 2022
Modality
Small Molecules
01

Overview

A Phase 2 trial of riminkefon in acute postoperative pain, sponsored by Hengrui. Status: unknown.

02

Drugs

riminkefon
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT05470049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05470049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call